Serum concentration of γGT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C

Gloria Taliani, Maria Concetta Badolato, Giovanni Nigro, Mara Biasin, Vieri Boddi, Caterina Pasquazzi, Mario Clerici

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Serum γGT levels and hepatic expression of tumor necrosis factor-α (TNF-α) are host factors that can independently predict the outcome of interferon (IFN) treatment in patients with chronic hepatitis C virus (HCV) infection. To explore whether a correlation exists between these two factors, we measured pretreatment γGT levels in serum and TNF-α mRNA levels in liver biopsies of chronic HCV patients. Seventy-two HCV patients treated with 3-to-5 million units of IFN-α three times a week were enrolled in the study. Treatment lasted 24 weeks and was followed by a 48-week follow-up period. Efficacy was assessed by measuring HCV RNA and alanine aminotransferase by the end of follow-up. Twelve patients (16.6%) showed a sustained biochemical and virological response. Normal pretreatment γGT levels, low HCV RNA titer, and infection with genotype other than HCV-1 were shown to be independent predictors of sustained response. Hepatic levels of TNF-α mRNA, quantified by polymerase chain reaction, were significantly higher in nonresponders (3.44 arbitrary units) compared to sustained responders (1.84 arbitrary units; P = 0.009). Values ≤3.12 arbitrary units independently predicted a sustained response to IFN (P = 0.014). Finally, TNF-α mRNA levels were significantly correlated with serum γGT levels (r = 0.79, P <0.0001). These findings suggest that serum γGT levels may represent a surrogate marker of hepatic TNF-α expression, thus explaining the importance of serum γGT levels in predicting treatment outcome.

Original languageEnglish
Pages (from-to)279-285
Number of pages7
JournalClinical Immunology
Volume105
Issue number3
DOIs
Publication statusPublished - Dec 1 2002

Fingerprint

Chronic Hepatitis C
Hepacivirus
Tumor Necrosis Factor-alpha
Biomarkers
Messenger RNA
Liver
Serum
Interferons
Virus Diseases
RNA
Viral Load
Alanine Transaminase
Genotype
Biopsy
Polymerase Chain Reaction

Keywords

  • γGT levels
  • HCV chronic hepatitis
  • HCV RNA kinetic
  • IFN treatment
  • Predictors of response
  • TNF-α

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Serum concentration of γGT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C. / Taliani, Gloria; Badolato, Maria Concetta; Nigro, Giovanni; Biasin, Mara; Boddi, Vieri; Pasquazzi, Caterina; Clerici, Mario.

In: Clinical Immunology, Vol. 105, No. 3, 01.12.2002, p. 279-285.

Research output: Contribution to journalArticle

Taliani, Gloria ; Badolato, Maria Concetta ; Nigro, Giovanni ; Biasin, Mara ; Boddi, Vieri ; Pasquazzi, Caterina ; Clerici, Mario. / Serum concentration of γGT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C. In: Clinical Immunology. 2002 ; Vol. 105, No. 3. pp. 279-285.
@article{508eaec11af742f188932fab845455a2,
title = "Serum concentration of γGT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C",
abstract = "Serum γGT levels and hepatic expression of tumor necrosis factor-α (TNF-α) are host factors that can independently predict the outcome of interferon (IFN) treatment in patients with chronic hepatitis C virus (HCV) infection. To explore whether a correlation exists between these two factors, we measured pretreatment γGT levels in serum and TNF-α mRNA levels in liver biopsies of chronic HCV patients. Seventy-two HCV patients treated with 3-to-5 million units of IFN-α three times a week were enrolled in the study. Treatment lasted 24 weeks and was followed by a 48-week follow-up period. Efficacy was assessed by measuring HCV RNA and alanine aminotransferase by the end of follow-up. Twelve patients (16.6{\%}) showed a sustained biochemical and virological response. Normal pretreatment γGT levels, low HCV RNA titer, and infection with genotype other than HCV-1 were shown to be independent predictors of sustained response. Hepatic levels of TNF-α mRNA, quantified by polymerase chain reaction, were significantly higher in nonresponders (3.44 arbitrary units) compared to sustained responders (1.84 arbitrary units; P = 0.009). Values ≤3.12 arbitrary units independently predicted a sustained response to IFN (P = 0.014). Finally, TNF-α mRNA levels were significantly correlated with serum γGT levels (r = 0.79, P <0.0001). These findings suggest that serum γGT levels may represent a surrogate marker of hepatic TNF-α expression, thus explaining the importance of serum γGT levels in predicting treatment outcome.",
keywords = "γGT levels, HCV chronic hepatitis, HCV RNA kinetic, IFN treatment, Predictors of response, TNF-α",
author = "Gloria Taliani and Badolato, {Maria Concetta} and Giovanni Nigro and Mara Biasin and Vieri Boddi and Caterina Pasquazzi and Mario Clerici",
year = "2002",
month = "12",
day = "1",
doi = "10.1006/clim.2002.5288",
language = "English",
volume = "105",
pages = "279--285",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Serum concentration of γGT is a surrogate marker of hepatic TNF-α mRNA expression in chronic hepatitis C

AU - Taliani, Gloria

AU - Badolato, Maria Concetta

AU - Nigro, Giovanni

AU - Biasin, Mara

AU - Boddi, Vieri

AU - Pasquazzi, Caterina

AU - Clerici, Mario

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Serum γGT levels and hepatic expression of tumor necrosis factor-α (TNF-α) are host factors that can independently predict the outcome of interferon (IFN) treatment in patients with chronic hepatitis C virus (HCV) infection. To explore whether a correlation exists between these two factors, we measured pretreatment γGT levels in serum and TNF-α mRNA levels in liver biopsies of chronic HCV patients. Seventy-two HCV patients treated with 3-to-5 million units of IFN-α three times a week were enrolled in the study. Treatment lasted 24 weeks and was followed by a 48-week follow-up period. Efficacy was assessed by measuring HCV RNA and alanine aminotransferase by the end of follow-up. Twelve patients (16.6%) showed a sustained biochemical and virological response. Normal pretreatment γGT levels, low HCV RNA titer, and infection with genotype other than HCV-1 were shown to be independent predictors of sustained response. Hepatic levels of TNF-α mRNA, quantified by polymerase chain reaction, were significantly higher in nonresponders (3.44 arbitrary units) compared to sustained responders (1.84 arbitrary units; P = 0.009). Values ≤3.12 arbitrary units independently predicted a sustained response to IFN (P = 0.014). Finally, TNF-α mRNA levels were significantly correlated with serum γGT levels (r = 0.79, P <0.0001). These findings suggest that serum γGT levels may represent a surrogate marker of hepatic TNF-α expression, thus explaining the importance of serum γGT levels in predicting treatment outcome.

AB - Serum γGT levels and hepatic expression of tumor necrosis factor-α (TNF-α) are host factors that can independently predict the outcome of interferon (IFN) treatment in patients with chronic hepatitis C virus (HCV) infection. To explore whether a correlation exists between these two factors, we measured pretreatment γGT levels in serum and TNF-α mRNA levels in liver biopsies of chronic HCV patients. Seventy-two HCV patients treated with 3-to-5 million units of IFN-α three times a week were enrolled in the study. Treatment lasted 24 weeks and was followed by a 48-week follow-up period. Efficacy was assessed by measuring HCV RNA and alanine aminotransferase by the end of follow-up. Twelve patients (16.6%) showed a sustained biochemical and virological response. Normal pretreatment γGT levels, low HCV RNA titer, and infection with genotype other than HCV-1 were shown to be independent predictors of sustained response. Hepatic levels of TNF-α mRNA, quantified by polymerase chain reaction, were significantly higher in nonresponders (3.44 arbitrary units) compared to sustained responders (1.84 arbitrary units; P = 0.009). Values ≤3.12 arbitrary units independently predicted a sustained response to IFN (P = 0.014). Finally, TNF-α mRNA levels were significantly correlated with serum γGT levels (r = 0.79, P <0.0001). These findings suggest that serum γGT levels may represent a surrogate marker of hepatic TNF-α expression, thus explaining the importance of serum γGT levels in predicting treatment outcome.

KW - γGT levels

KW - HCV chronic hepatitis

KW - HCV RNA kinetic

KW - IFN treatment

KW - Predictors of response

KW - TNF-α

UR - http://www.scopus.com/inward/record.url?scp=0036882319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036882319&partnerID=8YFLogxK

U2 - 10.1006/clim.2002.5288

DO - 10.1006/clim.2002.5288

M3 - Article

C2 - 12498809

AN - SCOPUS:0036882319

VL - 105

SP - 279

EP - 285

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -